What happens after you enquire about a clinical trial?

Sending an enquiry is a way to ask for information. It does not enrol you, confirm you are eligible or reserve a place. Recruitment status and available places can change, so a trial listing is a starting point, not a promise that a site can take you.

Depending on the study, a research site or recruitment team may contact you using the details you provided. They can explain the study, answer initial questions and ask whether you want to continue. If you do not recognise a call, ask which study and site it relates to before sharing more health information.

An early conversation or questionnaire may be called pre-screening. It asks a limited set of questions about the study's eligibility criteria, such as age, diagnosis, medicines or previous treatment. It can help identify whether a fuller discussion may be useful, but it is not the site's final eligibility decision.

If you may fit and want to continue, the team can explain the study and its informed consent process. Some initial questions may be asked before consent, while study-specific screening tests or procedures may require consent first. Ask what information or procedures are involved and when they would happen.

Possible next steps vary. The site may arrange another call or screening visit, ask you to wait while it checks capacity, explain that the study is not a match, or tell you that recruitment at that location has closed. A listing or enquiry does not guarantee that a place is available.

Before you decide, ask who will contact you, what happens next, how your information will be used and whom to call with questions. A guide to questions to ask before joining may help you prepare. You do not have to decide on the first call. Your usual health professional can help with medical questions, and the research team can explain the study.